GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of €18.00 million as of December 5, 2025. Its market cap has decreased by -52.42% in one year.

Market Cap

18.00M

Enterprise Value

36.74M

Revenue

945.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

€0.11

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 18.00M, a decrease of -92.86%. That is a compound annual growth rate of -24.48%.

Market Cap History

Date	Market Cap	% Change
Dec 5, 2025	18.00M	-45.54%
Dec 31, 2024	33.05M	28.79%
Dec 29, 2023	25.66M	-83.46%
Dec 30, 2022	155.20M	-39.23%
Dec 31, 2021	255.38M	-16.09%
Dec 31, 2020	304.35M	275.09%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	242.06B
Siemens Aktiengesellschaft	175.97B
Allianz SE	141.37B
Deutsche Telekom AG	131.00B
Siemens Energy AG	98.87B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	69.10B
Rheinmetall AG	68.36B
Deutsche Bank Aktiengesellschaft	59.35B

Market Cap Rankings